Inogen (INGN) | Stock Overview & Key Data
Inogen Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $287.79 on September 10, 2018
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Inogen
INGN
|
190.35M Micro-cap | 6.60% | 1.25% | 5.38% | -5.42% | -2.56% | 2.40% | -39.74% | -90.44% | -86.34% | -57.76% | -57.76% |
| 160.70B Large-cap | -2.02% | 4.97% | -19.35% | -30.98% | -28.60% | -34.98% | -16.97% | -20.08% | 135.84% | 255.56% | 329.52% | |
|
Stryker
SYK
|
126.25B Large-cap | 2.13% | 0.38% | -11.91% | -13.33% | -11.56% | -17.25% | 6.06% | 22.47% | 172.95% | 440.98% | 592.85% |
|
Monogram
MGRM
|
244.21M Micro-cap | 1.69% | 4.35% | 81.82% | 151.05% | 138.10% | 157.51% | -55.56% | -55.56% | -55.56% | -55.56% | -55.56% |
|
Sight Sciences
SGHT
|
237.20M Micro-cap | 8.42% | 0.80% | 34.22% | -39.59% | -32.89% | 24.21% | -39.50% | -84.31% | -84.31% | -84.31% | -84.31% |
|
Nevro
NVRO
|
224.09M Micro-cap | N/A | N/A | N/A | N/A | N/A | -56.06% | -92.38% | -94.65% | -89.12% | -76.92% | -76.92% |
Ownership & Short Interest
Calculate Your Inogen Investment Returns
Long-Term Investment Performance Analysis
Inogen stock price in Aug 2016 was $57.51, A $1,000.00 lump sum investment in Inogen made 9 years ago would be worth approximately $112.33 today, representing a negative return of -88.77%. This translates to an annualized return (CAGR) of -19.97%.
9 Years 9 Months Investment Scenario (Aug 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is INGN's 52-week high and low?
- In the last 52 weeks, Inogen reached a high of $9.13 (on October 22, 2025) and a low of $5.34 (on N/A).
- What is the market cap and P/E ratio for INGN?
- Curious about Inogen's size and valuation? Its market capitalization stands at 190.35M. When it comes to valuation, the P/E ratio (trailing twelve months) is -8.14, and the forward P/E (looking ahead) is -22.45.
- Does INGN pay dividends? If so, what's the yield?
- As for dividends, Inogen isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Inogen's main competitors or similar companies to consider before investing?
When looking at Inogen, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT160.70B Healthcare Medical Devices -34.98% -16.97% Stryker
SYK126.25B Healthcare Medical Devices -17.25% 6.06% Monogram
MGRM244.21M Healthcare Medical Devices 157.51% -55.56% Sight Sciences
SGHT237.20M Healthcare Medical Devices 24.21% -39.50% Nevro
NVRO224.09M Healthcare Medical Devices -56.06% -92.38% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Inogen Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Inogen's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -12.43%, the Debt to Equity ratio from the most recent quarter is 9.09, and its Gross Profit Margin stands at 43.12%.
- What is the recent revenue and earnings growth for INGN?
- Looking at Inogen's growth, its revenue over the trailing twelve months (TTM) was $349M. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.00%, and quarterly earnings saw a YoY growth of 2.05%.
- How much of INGN stock is held by insiders and institutions?
- Wondering who owns Inogen stock? Company insiders (like executives and directors) hold about 11.97% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 76.68%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.